We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
-20.95%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$63M
AUM Growth
+$5.46M
Cap. Flow
+$35.4M
Cap. Flow %
56.19%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AUTL
Autolus Therapeutics
AUTL
+$35.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$394M
$40.6M 64.38%
21,346,829
+14,000,000
+191% +$35.4M
FRLN
2
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$10.5M 16.59%
1,466,508
– –
ACHL
3
DELISTED
Achilles Therapeutics
ACHL
$9.98M 15.84%
11,086,909
– –
ADAP
4
DELISTED
Adaptimmune Therapeutics
ADAP
$2.01M 3.19%
1,377,294
– –

Similar funds

BAM
BTS Asset Management Lincoln, Massachusetts $25.9M AUM 2.16% 1-Year Est. Return
FCC
Florin Court Capital London, United Kingdom $26.5M AUM 34.2% 1-Year Est. Return
BWG
Berry Wealth Group Granbury, Texas $26.8M AUM 31.56% 1-Year Est. Return
LTM
Lotus Technology Management Orlando, Florida $27M AUM
TCM
Teza Capital Management Chicago, Illinois $27.3M AUM 29.09% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
BCM
BCK Capital Management Stamford, Connecticut $23M AUM 33.03% 1-Year Est. Return
SA
Strategic Advocates Logan, Utah $22.6M AUM 26.98% 1-Year Est. Return

Syncona Portfolio's Q4 2022 Portfolio in Review

As of Q4 2022, Syncona Portfolio held 4 positions worth $63M, up 9.5% from $57.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Syncona Portfolio deployed $35.4M of net new capital in Q4 2022, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio added most to Autolus Therapeutics in Q4 2022, an estimated $35.4M increase.
  • Syncona Portfolio's ten largest holdings make up 100% of its $63M portfolio in Q4 2022.
  • Syncona Portfolio opened 0 new positions and closed 0 in Q4 2022.
  • Syncona Portfolio's portfolio value rose 9.5% quarter-over-quarter to $63M.

Based on Syncona Portfolio's 13F filing for Q4 2022, filed 14 Feb 2023.